Table 4

Diagnostic accuracy of FIT for CRC and SBD at different cut-offs

Risk categoryFIT positivityCut-off (µg/g)SensitivitySpecificityPPVNPV
≥237.2CRC97.0 (94.5 to 98.5)64.9 (63.9 to 65.8)8.7 (7.8 to 9.7)99.8 (99.7 to 99.9)
HRA65.8 (61.0 to 70.3)64.1 (63.1 to 65.0)7.6 (6.7 to 8.5)97.7 (97.3 to 98.0)
IBD73.1 (68.6 to 77.2)64.4 (63.4 to 65.4)8.5 (7.7 to 9.5)98.1 (97.8 to 98.5)
SBD77.1 (74.6 to 79.5)68.2 (67.2 to 69.2)24.8 (23.4 to 26.3)95.6 (95.1 to 96.1)
≥1019.0CRC90.9 (87.2 to 93.8)83.5 (82.8 to 84.3)16.1 (14.4 to 17.8)99.6 (99.5 to 99.7)
HRA45.4 (40.5 to 50.3)82.2 (81.4 to 83.0)10.3 (8.9 to 11.7)97.1 (96.7 to 97.5)
IBD57.8 (53.0 to 62.6)82.8 (82.0 to 83.6)13.3 (11.8 to 14.9)97.7 (97.4 to 98.1)
SBD62.6 (59.8 to 65.4)87.0 (86.3 to 87.7)39.6 (37.4 to 41.8)94.5 (93.9 to 95.0)
≥1507.6CRC70.8 (65.6 to 75.7)94.6 (94.1 to 95.0)31.1 (27.8 to 34.6)98.9 (98.7 to 99.1)
HRA22.1 (18.2 to 26.4)93.0 (92.5 to 93.5)12.4 (10.1 to 15.0)96.4 (96.0 to 96.8)
IBD36.8 (32.2 to 41.5)93.7 (93.2 to 94.2)21.0 (18.1 to 24.1)97.0 (96.7 to 97.4)
SBD41.0 (38.2 to 43.9)96.9 (96.5 to 97.3)64.5 (60.9 to 67.9)92.4 (91.8 to 92.9)
  • 95% CIs within brackets.

  • CRC, colorectal cancer; FIT, faecal immunochemical test; HRA, high-risk adenoma; IBD, inflammatory bowel disease; NPV, negative predictive value; PPV, positive predictive value; SBD, serious bowel disease.